Loading company…
TRULIVE develops and sells interventional devices for structural heart and cardiovascular conditions.
Founded in 2019 and based in Jiangsu, China, TRULIVE develops, manufactures, and sells interventional cardiovascular devices, including transcatheter mitral, tricuspid, and aortic valve products and shockwave balloons. In March 2026, it raised Series D funding from CCB Private Equity Investment Management to advance research and development and product launches.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in